Tải xuống
Tóm tắt
Introduction: Gastrointestinal stromal tumors (GIST) are the most common mesenchymal neoplasms of the gastrointestinal system. The tumor arises from the middle layer of the gastrointestinal epithelium and can develop in organs such as the esophagus, stomach, small intestine, colorectal, or mesenteric. Histopathological examination is crucial in confirming GIST to choose appropriate therapeutics for patients. This study aims to explore the clinicopathological characteristics and evaluate the relationships between malignant risk classification according to Armed Forces Institute of Pathology criteria and the clinicopathological features of GISTs in a cohort of Vietnamese patients.
Methods: Eighty-nine patients with primary GIST who underwent surgery with primary curative intent between 2014 and 2019 at Hue Central Hospital, Vietnam, were evaluated for clinicopathological characteristics and immunohistochemical findings.
Results: The average age was 55.9 ± 11.9 years. Tumors > 2 - 5 cm accounted for 64.1%. The most common location was the stomach (48.5%). Rhomboid cell type was predominant (85.9%). All samples were positive for CD117, with Vimentin positive in 97.4%, and CD34 positive in 61.5%; no cases were positive for Desmin. High-risk GISTs dominated (46.9%), followed by intermediate risk (28.1%), low risk (20.2%), and very low risk (4.7%). Significant correlations were found between tumor necrosis and size, necrosis and the number of mitoses, and mucosal infiltration with tumor size.
Conclusions: There is a significant association between the risk level according to AFIP criteria and the necrosis or mucosal invasion of the tumor.
Tài liệu tham khảo
Soreide K, Sandvik OM, Soreide JA, Giljaca V, Jureckova A, Bulusu VR. Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies. Cancer Epidemiol. 2016; 40: 39 - 46.
Li ZS, Li Q. The latest 2010 WHO classification of tumors of the digestive system. Zhonghua Bing Li Xue Za Zhi. 2011; 40: 351 - 4.
Dematteo RP, Gold JS, Saran L, Gonen M, Liau KH, Maki RG, et al. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). Cancer. 2008; 112: 608 - 15.
Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998; 279: 577 - 80.
Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006; 23: 70 - 83.
Hechtman JF, DeMatteo R, Nafa K, Chi P, Arcila ME, Dogan S, et al. Additional Primary Malignancies in Patients with Gastrointestinal Stromal Tumor (GIST): A Clinicopathologic Study of 260 Patients with Molecular Analysis and Review of the Literature. Ann Surg Oncol. 2015; 22: 2633 - 9.
Li CF, Chuang SS, Lu CL, Lin CN. Gastrointestinal stromal tumor (GIST) in southern Taiwan: a clinicopathologic study of 93 resected cases. Pathol Res Pract. 2005; 201: 1 - 9.
Tran T, Davila JA, El-Serag HB. The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol. 2005; 100: 162 - 8.
Tryggvason G, Gislason HG, Magnusson MK, Jonasson JG. Gastrointestinal stromal tumors in Iceland, 1990-2003: the Icelandic GIST study, a population-based incidence and pathologic risk stratification study. Int J Cancer. 2005; 117: 289 - 93.
Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006; 130: 1466 - 78.
Brabec P, Sufliarsky J, Linke Z, Plank L, Mrhalova M, Pavlik T, et al. A whole population study of gastrointestinal stromal tumors in the Czech Republic and Slovakia. Neoplasma. 2009; 56: 459 - 64.
Chiang NJ, Chen LT, Tsai CR, Chang JS. The epidemiology of gastrointestinal stromal tumors in Taiwan, 1998-2008: a nation-wide cancer registry-based study. BMC Cancer. 2014; 14: 102.
Hu TH, Chuah SK, Lin JW, Chiu YC, Changchien CS, Wang CC, et al. Expression and prognostic role of molecular markers in 99 KIT-positive gastric stromal tumors in Taiwanese. World J Gastroenterol. 2006; 12: 595 - 602.
Nakamura N, Yamamoto H, Yao T, Oda Y, Nishiyama K, Imamura M, et al. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade. Hum Pathol. 2005; 36: 828 - 37.
| Đã xuất bản | 11-03-2025 | |
| Toàn văn |
|
|
| Ngôn ngữ |
|
|
| Số tạp chí | Số 62 (2020) | |
| Phân mục | Nghiên cứu | |
| DOI | 10.38103/jcmhch.2020.62.12 | |
| Từ khóa | Clinicopathology, immunohistochemistry, gastrointestinal stromal tumors (GIST). Clinicopathology, immunohistochemistry, gastrointestinal stromal tumors (GIST). |
công trình này được cấp phép theo Creative Commons Attribution-phi thương mại-NoDerivatives 4.0 License International .
Bản quyền (c) 2020 Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế